Medication Summary

Octreotide has limited benefit in treating patients with Ménétrier disease, but a therapeutic trial may be worthwhile.^[34]A monoclonal antibody against the epidermal growth factor receptor has been shown to be effective in treating Ménétrier disease. External elastic support is helpful in reducing peripheral edema.

Prednisone may be used in patients with total villous atrophy that is unresponsive to gluten restriction. Prednisone rapidly reverses the symptoms and signs of eosinophilic gastroenteritis and returns the serum albumin to the reference range. Medium-chain triglycerides are not helpful in hereditary intestinal lymphangiectasia. Specific treatment of infectious enteritides is indicated when present.

Class Summary

These agents have anti-inflammatory properties and cause profound and varied metabolic effects. Corticosteroids modify the body's immune response to diverse stimuli.

Prednisone (Orasone, Sterapred)

View full drug information

Immunosuppressant for treatment of autoimmune disorders; may decrease inflammation by reversing increased capillary permeability and by suppressing PMN activity. Stabilizes lysosomal membranes and also suppresses lymphocyte and antibody production.

Questions

Lee YT, Sung JJ. Protein-losing enteropathy. Gastrointest Endosc. 2004 Nov. 60(5):801-2. [QxMD MEDLINE Link].
Laine L, Garcia F, McGilligan K, et al. Protein-losing enteropathy and hypoalbuminemia in AIDS. AIDS. 1993 Jun. 7(6):837-40. [QxMD MEDLINE Link].
Waldmann TA, Wochner RD, Strober W. The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin. Am J Med. 1969 Feb. 46(2):275-85. [QxMD MEDLINE Link].
Rybolt AH, Bennett RG, Laughon BE, et al. Protein-losing enteropathy associated with Clostridium difficile infection. Lancet. 1989 Jun 17. 1(8651):1353-5. [QxMD MEDLINE Link].
Akgun A, Tani Acar E, Taner MS, et al. Scintigraphic diagnosis of protein-losing enteropathy secondary to amyloidosis. Turk J Gastroenterol. 2005 Mar. 16(1):41-3. [QxMD MEDLINE Link].
Cheong JL, Cowan FM, Modi N. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch Dis Child Fetal Neonatal Ed. 2004 Jul. 89(4):F367-9. [QxMD MEDLINE Link].
Pratz KW, Dingli D, Smyrk TC, et al. Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia. Medicine (Baltimore). 2007 Jul. 86(4):210-4. [QxMD MEDLINE Link].
Venkatesh B, Gough J, Ralston DR, et al. Protein losing enteropathy in critically ill adult patients with burns: a preliminary report. Intensive Care Med. 2004 Jan. 30(1):162-6. [QxMD MEDLINE Link].
Citrin Y, Sterling K, Halsted JA. The mechanism of hypoproteinemia associated with giant hypertrophy of the gastric mucosa. N Engl J Med. 1957 Nov 7. 257(19):906-12. [QxMD MEDLINE Link].
Overholt BF, Jeffries GH. Hypertrophic, hypersecretory protein-losing gastropathy. Gastroenterology. 1970 Jan. 58(1):80-7. [QxMD MEDLINE Link].
Fretzayas A, Moustaki M, Alexopoulou E, Nicolaidou P. Menetrier's disease associated with Helicobacter pylori: three cases with sonographic findings and a literature review. Ann Trop Paediatr. 2011. 31(2):141-7. [QxMD MEDLINE Link].
Ito R, Sakagami J, Kataoka K, et al. Chronic diarrhea and protein-losing gastroenteropathy caused by Dientamoeba fragilis. J Gastroenterol. 2004 Nov. 39(11):1117-9. [QxMD MEDLINE Link].
Murali A, Narasimhan D, Krishnaveni J, Rajendiran G. Protein losing enteropathy in systemic lupus erythematosus. J Assoc Physicians India. 2013 Oct. 61(10):747-9. [QxMD MEDLINE Link].
Lim DH, Kim YG, Bae SH, et al. Factors related to outcomes in lupus-related protein-losing enteropathy. Korean J Intern Med. 2015 Nov. 30(6):906-12. [QxMD MEDLINE Link].
Naddei R, Orlando F, Aloj G, De Matteis A, Alessio M. Differential diagnosis of hypoalbuminemia in childhood: protein losing enteropathy associated to systemic lupus erythematosus in a young boy. Eur J Gastroenterol Hepatol. 2020 Jan. 32(1):127-9. [QxMD MEDLINE Link].
Vyas H, Driscoll DJ, Cetta F, et al. Gastrointestinal bleeding and protein-losing enteropathy after the Fontan operation. Am J Cardiol. 2006 Sep 1. 98(5):666-7. [QxMD MEDLINE Link].
John AS, Johnson JA, Khan M, et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014 Jul 8. 64(1):54-62. [QxMD MEDLINE Link].
Dori Y, Keller MS, Fogel MA, et al. MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR Am J Roentgenol. 2014 Aug. 203(2):426-31. [QxMD MEDLINE Link].
Al Balushi A, Mackie AS. Protein-losing enteropathy following Fontan palliation. Can J Cardiol. 2019 Dec. 35(12):1857-60. [QxMD MEDLINE Link].
Patel JK, Loomes KM, Goldberg DJ, Mercer-Rosa L, Dodds K, Rychik J. Early impact of Fontan operation on enteric protein loss. Ann Thorac Surg. 2016 Mar. 101(3):1025-30. [QxMD MEDLINE Link].
Waldmann TA. Protein-losing enteropathy. Gastroenterology. 1966 Mar. 50(3):422-43. [QxMD MEDLINE Link].
Chau TN, Mok MY, Chan EY, et al. Evaluation of performance of measurement of faecal a(1)-antitrypsin clearance and technetium-99m human serum albumin scintigraphy in protein-losing enteropathy. Digestion. 2011. 84(3):199-206. [QxMD MEDLINE Link].
Furfaro F, Bezzio C, Maconi G. Protein-losing enteropathy in inflammatory bowel diseases. Minerva Gastroenterol Dietol. 2015 Dec. 61(4):261-5. [QxMD MEDLINE Link].
Bindl L, Buderus S, Bindl C, Lentze MJ. Protein-losing enteropathy: report of four cases and review of etiology, diagnostic work-up and treatment. Klin Padiatr. 2005. 217:201-10.
Florent C, L'Hirondel C, Desmazures C, et al. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 1981 Oct. 81(4):777-80. [QxMD MEDLINE Link].
Magdo HS, Stillwell TL, Greenhawt MJ, et al. Immune abnormalities in Fontan protein-losing enteropathy: a case-control study. J Pediatr. 2015 Aug. 167(2):331-7. [QxMD MEDLINE Link].
Albright F, Bartter FC, Forbes AP. The fate of human serum albumin administered intravenously to a patient with idiopathic hypoalbuminemia and hypoproteinemia. Trans Assoc Am Physicians. 1949. 204:62.
Ferrante M, De Hertogh G, Penninckx F, et al. Protein-losing enteropathy in Crohn's disease. Clin Gastroenterol Hepatol. 2005 Jun. 3(6):A25. [QxMD MEDLINE Link].
Stark ME, Batts KP, Alexander GL. Protein-losing enteropathy with collagenous colitis. Am J Gastroenterol. 1992 Jun. 87(6):780-3. [QxMD MEDLINE Link].
Ozeki T, Ogasawara N, Izawa S, et al. Protein-losing enteropathy associated with collagenous colitis cured by withdrawal of a proton pump inhibitor. Intern Med. 2013. 52(11):1183-7. [QxMD MEDLINE Link].
Nakaya Y, Kaku Hosokawa S, Kataoka Y, et al. Acute onset collagenous colitis associated with protein-losing enteropathy. J Gen Fam Med. 2017 Jun. 18(3):135-8. [QxMD MEDLINE Link]. [Full Text].
Jeffries GH, Chapman A, Sleisenger MH. Low-fat diet in intestinal lymphangiectasia. Its effect on albumin metabolism. N Engl J Med. 1964 Apr 9. 270:761-6. [QxMD MEDLINE Link].
Lee HJ, Rha MY, Cho YY, Kim ER, Chang DK. A case of protein supplement effect in protein-losing enteropathy. Clin Nutr Res. 2012 Jul. 1(1):94-8. [QxMD MEDLINE Link]. [Full Text].
Yeaton P, Frierson HF Jr. Octreotide reduces enteral protein losses in Ménétrier's disease. Am J Gastroenterol. 1993 Jan. 88(1):95-8. [QxMD MEDLINE Link].
Levitt DG, Levitt MD. Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol. 2017. 10:147-68. [QxMD MEDLINE Link]. [Full Text].
Kylat RI, Witte MH, Barber BJ, Dori Y, Ghishan FK. Resolution of protein-losing enteropathy after congenital heart disease repair by selective lymphatic embolization. Pediatr Gastroenterol Hepatol Nutr. 2019 Nov. 22(6):594-600. [QxMD MEDLINE Link].